ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[SMARCAL1, CCNH, SMC3, CHEK1, TRIM25, ESCO2, CDCA5, RAD21, BARD1, POLA1, FEN1, BTG2, BRCA1, BRCA2, CHAF1B, CHAF1A, ACTL6A, PARP9, SIRT1, RAD51C, PCNA, UNG, RAD54B, USP1, RAD54L, PMS1, GINS2, RPA1, GTF2H1, MLH1, RPA3, TRIP13, DCLRE1A, RUVBL2, RUVBL1, MEN1, LIG1, MSH6, MSH2, FANCD2, BLM, PSMD14, FANCI, HMGA1, ISG15, FANCG, COPS5, JMY, CDK1, EXO1, TOPBP1, RFC5, RFC3, RFC4, RFC1, RFC2, H2AFX, SMC1A, DTL, UHRF1, POLD3, CDC45, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RAD50, RAD51, POLE2]
GO:0007131;reciprocal meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;175.07189671554147;6.343086423195323;0.005859498828591432;0.7206263598461826;[RAD54B, RAD50, RAD51, RAD51C, RAD21, TRIP13]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[YAP1, GABRB1, TGFB2, TGFB1, CAV1, PTGER2, FOS, TYMS, THBS1, CLDN4, FOSB, CD38, TLR2]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[TOP2A, SPI1, TNFRSF13B, PLEK, SOX4, PDGFRA, ESCO2, TAL1, KIT, HOXB4, HOXB3, RBM47, PLD4, GATA3, JAM3, TGFB1, ACE, INHBA, PTPRC, BCL2, PTPN6]
GO:0045646;regulation of erythrocyte differentiation;7.0;0.7980440201809971;0.7499413753476991;9.34084218004034;77.59787612007705;5.9928839937622085;0.002597131080184449;0.6573957313958061;[SPI1, HMGB2, GATA1, ETS1, INPP5D, NCKAP1L, HOXA5, LYN, MED1, KLF13, ISG15, INHBA, MAPK14, MAFB, CDK6, TAL1]
GO:0097089;methyl-branched fatty acid metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;93.73125239075797;9.083926447120524;0.0031371006648681556;0.839552420951524;[SLC27A2]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0034501;protein localization to kinetochore;8.0;0.8436909121759173;0.7968454560879586;9.292052015870908;35.81813124301707;7.212124270218933;0.0011988006184784857;0.7438283705770736;[MIS12, CDK1, BUB1B, AURKB]
GO:0030263;apoptotic chromosome condensation;8.0;1.0;0.875;9.628524252492122;25.04782972205294;8.16763571524637;8.383283192138855E-4;0.7926932703116032;[TOP2A, ACIN1]
GO:2000491;positive regulation of hepatic stellate cell activation;6.0;1.0;0.8231203125901445;9.628524252492122;58.82470762909909;8.390779266560578;0.001968810025546158;0.7522251544931926;[PDGFRB, MYB, RPS6KA1]
GO:2000373;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity;7.0;1.0;0.8509193652572005;9.628524252492122;112.16415423977526;7.9853141584524145;0.0037540333012201187;0.7592887026755414;[PLSCR1, UHRF1]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, MCTS1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ACHE, DPYS, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, SLC7A9, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, NCF1, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, G3BP2, CXCL12, DMXL2, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, BIRC2, BIRC3, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CDC45, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, PRF1, IKZF1, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, HNF1B, MIF, KCTD12, KCTD15, TGFA, PTK2, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, NAPA, MIS12, CAPG, RXRA, CCT8, CD74, GCH1, RPA1, RPA3, NDUFAB1, NDUFB10, NDUFB11, TCF7, RASGRP1, CCNB1, LPXN, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, VIL1, NASP, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, GREM1, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, MX2, SOD2, TTC19, TEK, CDA, BIN2, NUP205, PRKCZ, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, CLINT1, TK1, BRD2, HCLS1, GSN, GTF2H1, TNF, CLU, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, ITPR3, NACC2, LSM3, HOPX, CDK1, PIK3C2A, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, PML, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, CDT1, AHCTF1, HBZ, RAD51C, UQCR10, AIF1, CTNNA1, NDUFA11, KNTC1, CHRNB4, NCF1C, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, H2AFX, AXIN2, DNM2, TGFBR3, COL6A2, COL6A1, COLEC12, CAMK2D, HIST1H2BK, LEF1, HSPD1, REPS2, RBMX]
GO:0009440;cyanate catabolic process;5.0;1.0;0.7902410118609202;9.628524252492122;206.6944268277435;9.083926447120524;0.006917876453017411;0.7547934328124444;[TST]
GO:0030261;chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.223059144383958;23.949217433387346;6.343086423195323;8.01558754599117E-4;0.6753050999230941;[TOP2A, CDCA5, NCAPG2, SMC4, SMC2, CDK1, ACIN1, NCAPD2, NCAPD3]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, IQGAP3, RASGRP1, G3BP2, JUN, HACE1, PLK2, DHCR24, COL1A2, BCL6, LAT, CDKN1A, ARHGAP6, ARHGAP4, RAC2, ARHGEF12, CHUK, RHOG, RHOH, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, PDPN, EPS8L1, EPS8L3]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, CDCA5, RAD21, HMOX1, SFN, BARD1, LYN, MCTS1, PLK2, PLK1, CDKN1A, BTG2, CHAF1B, CHAF1A, CTLA4, ACTL6A, SIRT1, UNG, USP1, PMS1, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, CUL5, FOXO1, MAP2K6, FANCI, FANCG, COPS5, BCL6, CNOT3, BCL3, CDK1, BCL2, BCL2L1, MCM7, EXO1, TLK1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, TFDP1, DTL, PPP1R15A, UHRF1, CDC45, RBBP8, POLR2E, E2F1, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, DONSON, PML, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, TRIM25, SOX4, ESCO2, MIF, EPHA2, POLA1, TOP2A, FEN1, SUV39H1, BRCA1, BRCA2, PARP9, RAD51C, SGK1, YAP1, SP100, PCNA, RAD54B, RAD54L, GINS2, RPA1, MLH1, RPA3, NEDD4, TRIP13, DCLRE1A, LIG1, FANCD2, PSMD14, CCNB1, HMGA1, ISG15, JMY, TOPBP1, H2AFX, IRF7, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:0042148;strand invasion;7.0;0.8436909121759173;0.7727648213451592;9.456673995565463;149.0421272461911;7.8311634786251565;0.0049883058697239;0.7514054297404357;[RAD51, RAD51C]
GO:0045656;negative regulation of monocyte differentiation;9.0;1.0;0.896240625180289;9.628524252492122;842.1281654798506;7.8311634786251565;0.028185271832466503;0.7967266896635242;[CDK6, INPP5D, HOXA7]
GO:0000076;DNA replication checkpoint;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;54.456905800140625;6.8867018697843045;0.0018226236290973575;0.7271862538851576;[CDT1, CDC45, CDC6, TOPBP1, NAE1]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, THY1, PRKCZ, EPB41L5, CCR7, CD36, JUP, CCL21, CDK6, CEACAM6, NINJ1, TEK]
GO:0046078;dUMP metabolic process;11.0;0.8933024483968273;0.8790801765280758;9.566003895510788;882.6830739380919;7.8311634786251565;0.029542608121515816;0.8329150168128974;[TYMS]
GO:0050680;negative regulation of epithelial cell proliferation;6.0;0.7307253602413294;0.6884829927108091;8.690254613899192;65.19530579150691;4.989581884898423;0.0021820282128758306;0.5782877622231366;[SPARC, PRL, PTPRK, BRCA2, PHB2, TNF, DUSP10, MEN1, MED1, MEF2C, EREG, TGFBR3, CEACAM1, SFRP2, NLRC3, GATA3, THBS1, CCL2, SFN, TGFB2, TGFB1, CAV2, VDR, CAV1, NR2F2, SULF1, CDK6, SNAI2]
GO:0000070;mitotic sister chromatid segregation;6.0;1.0;0.8231203125901445;9.628524252492122;56.84344269090966;6.311337724880743;0.0019024988710876387;0.6458824173477649;[MIS12, PLK1, CDCA8, SMC1A, TUBG1, SMC4, ZWINT, NDC80, KIF18A, RAN, MAD2L1]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, CEBPB, PCNA, C5AR1, IHH, ADM, TYMS, ATIC, HMOX1, IL10, MED1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, CDK1, LCP1, EZH2]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[CHEK1, SLBP, BLM, BARD1, CDT1, CDC6, POLA1, POLA2, NASP, CDK1, ACHE, FEN1, MCM7, BRCA1, CHAF1B, CHAF1A, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, RMI1, DBF4, MCM3, MCM4, MCM6, DTL, MCM2, CDC45, POLD1, RBBP8, RRM1, RRM2, RPA1, DONSON, RAD50, POLE2, RPA3, DNAJA3, SSBP1]
GO:0006266;DNA ligation;7.0;0.7763722522362496;0.7391054913753253;9.35659053700848;149.0421272461911;7.004484905440688;0.0049883058697239;0.7091290490632969;[TOP2A, LIG1, HMGB2]
GO:0000712;resolution of meiotic recombination intermediates;5.0;1.0;0.7902410118609202;9.628524252492122;26.252913020668647;6.8867018697843045;8.786613727139965E-4;0.6424272657460779;[TOP2A, BLM, MLH1]
GO:0006267;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;77.92043580405796;8.67846133901236;0.0026079268625224215;0.8400575416471059;[CDC45]
GO:0006265;DNA topological change;7.0;1.0;0.8509193652572005;9.628524252492122;171.38190676714436;7.57984905034425;0.005735998185793931;0.738553198190834;[TOP2A, HMGB2]
GO:0070192;chromosome organization involved in meiotic cell cycle;5.0;0.7043150770688792;0.6423985503953599;8.567652291806858;44.78603005185074;5.682729065458369;0.0014989481210252074;0.5808560405423884;[BUB1B, SMC4, SMC2, PPP2R1A, BUB1, MLH1, RAD50, RAD51, RAD51C, CCNE2, CCNE1, FANCD2, NCAPD2, NCAPD3, TRIP13]
GO:0006268;DNA unwinding involved in DNA replication;8.0;0.8259837884571596;0.7879918942285797;9.34084218004034;24.41922106263308;7.57984905034425;8.172893530941673E-4;0.7626338329336335;[PURA, RAD51, MCM7, HMGA1, RPA1, MCM4, MCM6, MCM2]
GO:0045668;negative regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;170.3268387162597;6.015873511986907;0.0057006860076304205;0.6307723637598831;[IGFBP5, TWIST1, TMEM64, AXIN2, TNF, GREM1, CDK6, ID1, HOXA2, MEN1]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, PLEK, F13A1, CTSW, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, SERPING1, TLN1, VCL, CFD, STXBP2, PDGFA, THBS1, PSAP, FLNA, A2M, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, SELP, TF, CD9, PF4]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[BRCA2, CENPA, RACGAP1, STMN1, ECT2, MYH10, CEP55, CDT1, PLK1, CKAP2, CIT, KIF4A, KIF20A]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, PML, EREG, BTC, CCNA2, CDK6, NDUFS4]
GO:1990426;mitotic recombination-dependent replication fork processing;10.0;1.0;0.9152410118609203;9.628524252492122;328.81961107458824;9.083926447120524;0.011005296464229153;0.8797934328124444;[RAD51, BRCA2]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[GINS2, MCM7, CDC6, POLA1, PURA, POLA2, CDC34, CDC45, CCNE2, CCNE1, MCM3, MCM4, MCM6, TOPBP1, MCM2]
GO:0036344;platelet morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;47.452274261266446;9.083926447120524;0.0015881849152503491;0.7876727335416686;[C1GALT1C1, ACTN1]
GO:0000727;double-strand break repair via break-induced replication;10.0;1.0;0.9152410118609203;9.628524252492122;521.7226431472901;8.16763571524637;0.01746158734624478;0.8329342821725234;[GINS2, CDC45]
GO:0060252;positive regulation of glial cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;465.4406966640378;7.292166977892469;0.015577881247913653;0.769162383550154;[LYN, PRKCH, MYB, LTA]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[BLM, FEN1, PSMD14, BRCA1, BRCA2, RAD54B, CDC45, RBBP8, RAD54L, GINS2, H2AFX, RPA1, RAD50, RAD51, RAD51C, RPA3]
GO:0000722;telomere maintenance via recombination;9.0;0.9326813400603323;0.8625812952104552;9.593432932680852;337.7230221555657;7.212124270218933;0.011303285620559713;0.7650689957573628;[RAD50, RAD51, RAD51C, BRCA2]
GO:0003323;type B pancreatic cell development;7.0;1.0;0.8509193652572005;9.628524252492122;37.346163459204256;7.379178354882098;0.001249942481614558;0.728290889492758;[CDK6, DLL1]
GO:0010529;negative regulation of transposition;5.0;0.8653626801206646;0.7229223519212526;9.271849308553389;41.7579727432223;6.781341354126479;0.0013976017679800644;0.6370391240755715;[MYBL1, APOBEC3A, APOBEC3B]
GO:0035928;rRNA import into mitochondrion;9.0;1.0;0.896240625180289;9.628524252492122;117.02759949286228;8.67846133901236;0.00391680843702438;0.8400575416471059;[TST]
GO:2000145;regulation of cell motility;5.0;0.46812423412493653;0.5243031289233886;6.883086519318291;34.54403569627484;3.0677692874221707;0.001156157787140571;0.44712687588555144;[SERPINE1, SPINT2, ADARB1, MYLK, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, PRKCE, CLDN7, PADI2, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, FN1, NR2F2, COL1A1, NOX4, SNAI2, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, TACR3, SIRT1, F3, TMEFF2, PLCB1, HBEGF, ENG, PTAFR, PTGS2, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, SULF1, COL3A1, PKN1, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, PHLDA2, SEMA6A, IGFBP5, IGFBP3, F2R, TPM1, ADAM9, ADAM8, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, DAB2, CXCL12, PTPRC, CDK6, BCL2, PLXNB2, ITGB3, PIK3CD, PIK3C2A, CYR61, DUSP10, EMILIN1, ITGA4, XCL2, XCL1, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4A, SEMA4B, TIE1, KLF4, IL1RN, SPARC, ICAM1, LGALS3, IL1R1, ACTN4, MIF, EREG, BTC, SFRP2, IL23A, PFN1, TRIB1, EPHA2, TWIST1, CCR1, TNFSF14, PPBP, PTK2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, PTPRK, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, GAB1, IL1A, CEACAM1, CEACAM6, IL1B, KIT, SGK1, SP100, AIF1, GNAI2, PAK1, CXCR3, CXCR2, PDPN, CTNNA1, MPP1, CD74, IL33, PODN, DLC1, ETS1, PLAU, ARHGDIB, IL6R, PDGFRB, PDGFRA, POSTN, VCL, C5AR1, FBLN1, STAP1, TGFB2, TGFB1, SELP, VIL1, IL6, BMP2, NR4A3, FES, DOCK5, CXCL6, CXCL9, DOCK4, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, DDX58, ARAP3, MMP9, DCN, FGR, GREM1, IFNG, LAMA2, LAMA4, LAMA3, LEF1, THBS1, SPOCK3, EGF, LAMB1, MAPK14, SOD2, TEK]
GO:0033189;response to vitamin A;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;42.3983228833862;6.781341354126479;0.0014190337108936392;0.6977174774718518;[ARG1, ABCB4, RARA, TYMS]
GO:0051315;attachment of mitotic spindle microtubules to kinetochore;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;27.921945865447032;7.379178354882098;9.345223999966889E-4;0.6273715242355574;[CENPE, CDT1, SEH1L, MIS12, NUF2, KIF2C, NDC80, MAD1L1]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, STRADB, MSH2, IFNG, RRAGD, GAS1, PPP1R15A, CUL5, THBS1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, DHCR24, INHBA, PML, CDK6, FAP, JMY]
GO:1905463;negative regulation of DNA duplex unwinding;8.0;0.8933024483968273;0.8216512241984136;9.5544162803384;116.67017030639651;9.083926447120524;0.003904845603818755;0.839552420951524;[TOP2A, MCM2]
GO:1905342;positive regulation of protein localization to kinetochore;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;8.390779266560578;0.002466909593039506;0.7800242071602487;[CDT1, NDC80]
GO:1905341;negative regulation of protein localization to kinetochore;7.0;1.0;0.8509193652572005;9.628524252492122;73.78875676133134;9.777073627680469;0.0024696432832320894;0.8509193652572005;[CDT1]
GO:0007052;mitotic spindle organization;7.0;0.8259837884571596;0.7639112594857803;9.280217558223907;96.21539173928952;5.486614186532078;0.0032202425732832385;0.6315050699101035;[KIF11, AURKB, CDC20, CCNB1, STMN1, NUF2, FLNA, STIL, PLK2, TUBG1, NDC80, CENPE, KIF4A, BIRC5, RAN, BIRC2, SPC25, BIRC3]
GO:0036297;interstrand cross-link repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;5.905872616772578;0.006126539929698291;0.6770266002729131;[DCLRE1A, FANCI, RPA1, FANCG, MSH6, RAD51, MSH2, FANCD2, RPA3]
GO:0006635;fatty acid beta-oxidation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;579.9307786885206;5.734022359845919;0.019409761258888828;0.6894787953221185;[HSD17B4, ETFA, ACAT1, ACADM, HIBCH, EHHADH, SLC27A2]
GO:0035999;tetrahydrofolate interconversion;8.0;1.0;0.875;9.628524252492122;262.53585291497376;7.292166977892469;0.008786838730136297;0.747921758369865;[MTHFD1, TYMS]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[PRKCD, VRK1, AURKB, CCNA2, CCNB1, CHEK1, CDK1, PKN1]
GO:0072425;signal transduction involved in G2 DNA damage checkpoint;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;196.6208089386036;7.292166977892469;0.006580721527935406;0.769162383550154;[CHEK1, PLK1, BRCA1, DTL]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, MX2, CARD9, LILRB1, PML]
GO:0010216;maintenance of DNA methylation;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;8.16763571524637;0.0049883058697239;0.7686126355688037;[UHRF1]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[FMR1, TNF, CLU, AKT1, ADAM9, ADAM8, TRIB1, FOXO1, BARD1, OSBPL7, PLK2, TNFSF12, CAV1, PLK1, PTK2, DAB2, CCDC22, LRRK2, TNFAIP3, TNFRSF1B, CBFA2T3, RNF144B, IFNG, IL1B, DTL, CEBPA, LRP1, LRP2, IL33, EGF, PSMC6, NEDD4, PSMC2]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MED1, MEF2C, HNF1B, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, VIL1, FA2H, BMP2, DAB2, CDK1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, GREM1, ELF3, TST, RARA, FAM20C, YAP1, TAGLN, CEBPB, CSTA, HDAC2, PCNA, LEF1, RXRA, E2F7, CDX2, KLF4, USH2A, GRHL2]
GO:2000845;positive regulation of testosterone secretion;9.0;1.0;0.896240625180289;9.628524252492122;439.69537685412286;9.083926447120524;0.014716208563159352;0.8607930461318132;[MYB]
GO:0031145;anaphase-promoting complex-dependent catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.221725566191056;0.011732800519056534;0.7334203466557586;[BUB1B, AURKB, CDC20, CCNB1, UBE2C, PLK1, CDK1, MAD2L1]
GO:0090308;regulation of methylation-dependent chromatin silencing;11.0;0.8933024483968273;0.8790801765280758;9.5544162803384;378.0478930493778;7.57984905034425;0.01265292275934795;0.8200627852632958;[UHRF1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, SOCS2, MARCH3, MARCH1, BCL2, ARRB1, ARRB2, BIRC5, DTL, BIRC2, BIRC3, UHRF1, NLRC4, ZNRF1, RNF24, CDC20, HERC5, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144B, PDZRN3, PCNA, PCNP, NEDD4, KLHL14, DTX3, UBE2C, UBE2M, TNFAIP3, HIST1H2BK]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ICAM1, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, DPP4, NCAM1, SLAMF1, GPR15, CDK1]
GO:0044539;long-chain fatty acid import;11.0;1.0;0.9324289523296623;9.628524252492122;75.02792930111643;7.474488534686424;0.0025111172729558144;0.8146746435927894;[ACSL1, CD36, SLC27A2]
GO:0014002;astrocyte development;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.09911675737102;6.832634648514029;0.001141266750656509;0.639662265535933;[CDK6, PLP1, TSPAN2, DLL1, S100A9, S100A8]
GO:0030174;regulation of DNA-dependent DNA replication initiation;9.0;0.7508913569872202;0.7716863036738992;9.326243380619188;154.23465726608282;7.9853141584524145;0.005162095176516053;0.8046099625986299;[CDT1]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[CDT1, JUN, PCNA, EREG, CST3, DBF4, CDK1, E2F7]
GO:0044774;mitotic DNA integrity checkpoint;8.0;0.8259837884571596;0.7879918942285797;9.405380701177911;188.74061193661657;5.769740442447999;0.006316978425995768;0.6700647945471605;[TOP2A, BLM, TOPBP1, NAE1, FANCI, DONSON, CDC6, MSH6, MSH2, CDK1]
GO:0048699;generation of neurons;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.75937296335754;7.474488534686424;7.282666309192915E-4;0.6724867031240476;[TGFB2, CDK6, CDH1, CIT]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[LGALS1, PSMD3, SKP2, ESCO2, MXRA8, SPARCL1, SDC2, C3, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM20C, FSTL1, CST3, SPP1, PSMC6, PSMC2, NUCB1, TNC, MEN1, IGFBP5, CISH, APLP2, IGFBP3, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, UBA3, CCDC22, UBE2M, FBN1, LAMC1, CYR61, VCAN, DTL, LAMB1]
GO:0045624;positive regulation of T-helper cell differentiation;12.0;0.8436909121759173;0.8699657686781033;9.572434785841079;2153.6076355307396;6.7325511899570465;0.07207930944017535;0.7924232935401965;[CD86, ANXA1, RIPK2, CD80, IL18, PRKCZ, IL23A, HLX, MYB, RARA, NLRP3, CCL19, IL12RB1]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, PPP2R1A, SKP2, TUBG1, CDC25A, CIT, DNM2, CCNA2, MELK, PLCB1, PKMYT1, CCNB2, CCNB1, PRKAR2B, PLK1, WEE1, CDK1, CDK14]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, BTG2, PCNA, CCNB1, E2F1, SFN, E2F7, SOX4, PLK2, PML, TFDP1, CNOT3, CDK1]
GO:0045870;positive regulation of single stranded viral RNA replication via double stranded DNA intermediate;9.0;1.0;0.896240625180289;9.628524252492122;106.55819935642852;9.777073627680469;0.003566407036306347;0.896240625180289;[TOP2A]
GO:0031938;regulation of chromatin silencing at telomere;11.0;0.8933024483968273;0.8790801765280758;9.551563211355994;304.6981139023377;9.083926447120524;0.010197971661811984;0.8969813732811862;[CDC45]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[CDT1, PCNA, RRM2, GFI1, CDC6, TYMS, POLA1, TFDP1, CDC45, CCNE1, E2F1, FBXO5, E2F7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, MCM7, GMNN, SKP2, CDC25A, DBF4, CDC34, CCNE2, CCNE1, MCM3, MCM4, RHOU, MCM6, BCAT1, MCM2, CUL5, PRIM1, IQGAP3, GSPT1, CDC45, RBBP8, RANBP2, RANBP1, CDT1, CDKN2C, PLK2, RPA1, CDC6, INHBA, POLA1, POLA2, WEE1, CDK6, NASP, POLE2, RPA3]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[YAP1, CDKN1A, BLM, FIGNL1, ECT2, EGR1, TGFB1, H2AFX, MAPK14, SIRT1, DNM2, RAD51, SFRP2, NOX4, BCL2L1]
GO:0032465;regulation of cytokinesis;6.0;0.5930994877375815;0.6196700564589352;8.140447197062288;31.798591743249187;5.358233019883872;0.0010642702487719462;0.5971405984103235;[AHCTF1, BRCA2, NUP62, PRKCE, TAS2R13, CIT, KIF20A, CXCR5, AURKB, RACGAP1, ECT2, E2F7, SVIL, PLK1, CDC6, PRC1, CALM3, BCL2L1]
GO:0016554;cytidine to uridine editing;9.0;1.0;0.896240625180289;9.628524252492122;133.9430579393504;7.292166977892469;0.0044829536083040925;0.769162383550154;[RBM47, APOBEC3A, APOBEC3B]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[UHRF1, BRCA1]
GO:0060574;intestinal epithelial cell maturation;6.0;1.0;0.8231203125901445;9.628524252492122;41.35061092186203;8.390779266560578;0.0013839677344209735;0.7522251544931926;[CDKN1A, TYMS, HOXA5]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[TNFAIP3, ZNRF1, HACE1, UBE2C, CDC34]
GO:0045995;regulation of embryonic development;5.0;0.5017827139744404;0.5411323688481404;6.887684228566921;27.37613670804801;4.981283082083729;9.162546586948941E-4;0.5449840603320351;[IL1RN, CELSR1, HNF4A, PHLDA2, PRKACB, IL10, HNF1B, DUSP6, SFRP2, PLCB1, LAMA2, LAMA4, LAMA3, GATA3, DLL1, GATA1, RACGAP1, FZD1, CDX2, CDX1, KLF4, SULF1, COL5A1, COL5A2, CDK1, FOXA2]
GO:0043697;cell dedifferentiation;3.0;0.8653626801206646;0.6308016526504768;9.292052015870908;23.14253743147029;7.9853141584524145;7.745599008998212E-4;0.6064896500084854;[CDK6]
GO:0006513;protein monoubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.574457031221845;155.4032479663248;5.649939242635378;0.005201206855589802;0.704179167478338;[UHRF1, BMI1, TRIM25, DTL]
GO:1902426;deactivation of mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1950.7008717452545;9.777073627680469;0.0652882026605069;0.9625549647676366;[CDT1]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[, CDC20, PSMD3, TRIM25, SKP2, CDC34, HACE1, PLK1, TGFB1I1, SIRT1, PSMA5, PSMA6, RNF144B, PSMA3, PSMA4, PSMA2, PCNP, USP1, RANBP2, RANBP1, USP9Y, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, RNF43, PSMD14, CUL5, CCNB1, WFS1, UBE2C, CDK1, ARRB1, ARRB2, DTL, BIRC2, UHRF1, VPS4B, AURKB, ZNRF1, TBX21, RNF24, PML]
GO:0000098;sulfur amino acid catabolic process;8.0;0.7090535922965819;0.729526796148291;9.168991923113682;455.51898126546024;7.212124270218933;0.015245810362487405;0.7438283705770736;[TST]
GO:0006625;protein targeting to peroxisome;10.0;0.8933024483968273;0.861892236059334;9.56183287799345;237.37488197280172;5.572381008289503;0.007944723676105511;0.7002128357670632;[ZFAND6, EHHADH, SLC27A2, HSD17B4]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[PPP2R1A, TUBG1, PRKAR2B, PLK1, CDK1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, IGKC, CARD9, NR1H4, KIR3DL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, PSMD3, PRSS3, UQCRC1, PRKCQ, UQCRC2, CFB, CFD, ENPEP, CFI, GATA3, ADAMTS12, CFP, C2, C3, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, IFIH1, MMP28, OLR1, RIPK2, ACTL6A, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, RNF43, FBXW2, CDC25A, ADAM2, ADAM9, ADAM8, ADAM7, CUL5, AEBP1, TMEM27, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, CDK1, ARRB1, ARRB2, SCPEP1, ADAMTS1, ADAMTS20, ASPH, MEP1A, DTL, BIRC2, BIRC3, C1S, C1R, UHRF1, HM13, VPS4B, FGL2, ZNRF1, RNF24, GZMA, GZMB, PML, GZMH, GZMK, GZMM, EIF3F, CDC20, ANPEP, TRIM25, SKP2, CDC34, CFTR, CTSZ, CTSW, BRCA1, PCSK6, CTSS, CTSH, CTSG, CTSB, MME, RNF144B, C1QB, C1QA, CD5L, TMPRSS2, PCNP, IGKC, PERP, RANBP2, RANBP1, IL33, GCA, FAP, NEDD4, MAD2L1, C1QC, FCN1, IHH, BUB1B, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, HTRA1, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, TGFB1, UBE2C, GGH, ISG15, NFKBIA, UBA3, IGKV3-20, TNFAIP3, MMP1, DDX58, MMP2, MMP8, MMP9, CCNA2, LTF, AURKB, TBX21, NRIP3, CPVL, RBMX]
GO:0010569;regulation of double-strand break repair via homologous recombination;9.0;0.8436909121759173;0.8180860812682478;9.523163736834295;184.48234756552796;6.221725566191056;0.00617445814968456;0.7144199599751273;[BLM, RAD51, FIGNL1, CHEK1]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[MSH6, FANCI, BLM, DONSON, CDK1, TOPBP1]
GO:0035563;positive regulation of chromatin binding;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;31.32148238131123;7.292166977892469;0.0010483018277984315;0.6631627702307852;[CDT1, GMNN, PARP9]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[TOP2A, ZWILCH, BUB1B, BRCA1, KNTC1, TOPBP1, MSH6, MSH2, MAD1L1, BLM, AURKB, NAE1, BUB1, FANCI, TGFB1, PLK2, PLK1, DONSON, CDC6, ZWINT, WEE1, CENPF, CDK1, TRIP13, MAD2L1, BCL2L1]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, CETN3, CEP120, HEPACAM2, TUBE1, BRCA1, UXT, FES, NUP62, CDK1]
GO:1902036;regulation of hematopoietic stem cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;97.61516402498306;6.558197802812269;0.003267091691972132;0.6863059058804069;[YAP1, LMO2, EIF2AK2, GATA3, GATA1, TAL1, MYB]
GO:0033262;regulation of nuclear cell cycle DNA replication;9.0;0.7140352122741334;0.7532582313173557;9.240758721483358;171.6907107923128;7.212124270218933;0.00574633357861074;0.7650689957573628;[CDT1, DACH1, BCL6]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, KIF20A, MSR1, EGR2, POLA2, TF, CD24, CD3G, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, PLEK, NUP62, YWHAH, NUP133, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, HOMER3, CUBN, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, TLK1, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, LTBP2, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, RORA, PHB2, ETS1, SLC8A1, LOXL2, AQP1, ICAM1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ADAM8, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, BCL2, NOX4, CD24, ALAS2, SUV39H1, ADM, ALAD, CD38, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, BIRC2, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, FABP1, TEK]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, HDAC2, TGFB1, MYB, F2R, IHH, ARRB2, ENG, CTGF]
GO:0031639;plasminogen activation;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;103.96951844736539;7.379178354882098;0.003479766215941568;0.7523715242355574;[PLAU, F11, DHCR24]
GO:0015949;nucleobase-containing small molecule interconversion;6.0;0.7671156992804218;0.7066781622303554;9.271849308553389;109.52544358977337;6.409777797693995;0.003665718030449963;0.6509166472493662;[DTYMK, TYMS, NME1]
GO:0019088;immortalization of host cell by virus;8.0;1.0;0.875;9.628524252492122;54.80099909185045;9.777073627680469;0.0018341401219070278;0.875;[TYMS]
GO:0071897;DNA biosynthetic process;7.0;0.7090535922965819;0.7054461614054914;9.249034630787218;573.3007402310989;5.058574756385375;0.01918785983836615;0.609615113546532;[BRCA2, CTGF, TRIM25, TK1, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, SIRT1, DTL, BLM, PCNA, TYMS, POLD3, POLD1, RPA1, ISG15, POLA1, POLA2, RAD50, CENPF, POLE2, RPA3]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, KIF4A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0033490;cholesterol biosynthetic process via lathosterol;8.0;1.0;0.875;9.628524252492122;431.4567121071901;8.390779266560578;0.014440467868396407;0.8041048419030481;[DHCR24]
GO:0010390;histone monoubiquitination;11.0;0.8933024483968273;0.8790801765280758;9.589303539338841;498.95626046972137;6.375876246018314;0.016699617006440744;0.7584915600596062;[UHRF1, BMI1]
GO:0014075;response to amine;5.0;0.7980440201809971;0.6892630219514189;9.223059144383958;29.79647000066773;6.139487467954083;9.972610358403309E-4;0.6042146864874571;[HDAC2, ARG1, CAD, NME1, ICAM1, NR4A2, CDK1, DRD4]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, RXRA, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[CALML4, UXT, CDC20, STMN1, FBXO5, MAP1B, KIF20A, LLGL2, PRKCZ, FIGNL1, PLK2, PLK1, PTK2, CETN3, KIF11, NUF2, TUBG1, KIF2C, CENPA, FLNA, RANBP2, RANBP1, TUBE1, CENPE, SPC25, CEP120, GAS2L3, MAP7D1, MAP7D2, CCNB1, STIL, NEK7, NDC80, KIF18A, FES, KIF4A, CDK1, NAV1, ASPM, PSRC1, BIRC5, BIRC2, BIRC3, VPS4B, AURKB, WEE1, PRC1, RAN]
GO:0009725;response to hormone;4.0;0.5257808277979137;0.5128904138989568;7.033269545535256;21.85620986101781;3.280298637494607;7.315076747364311E-4;0.41775462487096104;[CYFIP1, IL1RN, PID1, SPARC, AQP1, ICAM1, EDNRB, AKT1, PRKACB, JUNB, PTGDR, MED1, MEF2C, PRKCE, PRKCD, EREG, SFRP4, CLDN4, POR, ADCY9, PRKAR1B, SIK1, ABCB4, SLC30A10, GATA1, PRKAR2B, LYN, EGR1, EGR2, JUN, CDC6, NR2F2, COL1A1, SDC1, EZH2, ROBO2, CDKN1A, GABRB1, BTG2, ADM, BRCA2, CTSS, TIMP2, CTSH, TIMP3, CD38, CCR7, TIMP1, CTSB, IL10, EDN1, ANXA1, DUSP1, ANXA3, ARG1, TACR3, AVPR1A, FOS, SIRT1, NME1, CEACAM1, IL1B, KIT, RARA, MMP19, HCLS1, ACSBG1, ENG, TLR2, YAP1, PCNA, PTGER2, PTAFR, PTGS2, TYMS, AIF1, GNAI1, CST3, PAK1, SPP1, CCL19, CCL21, SORT1, SORBS1, POU4F1, FOSB, RAMP1, TNC, IHH, TNF, ETS1, CTGF, SESN3, RUVBL2, MEN1, PDGFRB, GHSR, LHCGR, POSTN, IGFBP5, LMO2, CYBB, ADCYAP1, RAB31, LOX, ADAM9, FECH, FOXO1, ACAT1, SOCS2, IGFBP7, CYC1, GAS2L1, EIF2B3, TGFB2, TGFB1, CAV1, GGH, DHCR24, INHBA, NFKB1, NR4A2, NR4A1, GH1, IL6, KIF18A, CXCL12, NR4A3, NASP, BCL2, ALPL, FBN1, HMGB2, FHL2, GHR, ALAD, HHEX, CA2, UQCRFS1, GLP2R, CAD, TGFBR3, CCNA2, RETN, THBS1, P2RY6, PLN, RBBP8, FYN, CSK, TSHR, CD4, TEK]
GO:0006699;bile acid biosynthetic process;8.0;1.0;0.875;9.628524252492122;493.34951140512965;6.481236761676141;0.01651196416099542;0.7064507494004503;[OSBPL7, HSD17B4, CH25H, SLC27A2]
GO:0001561;fatty acid alpha-oxidation;9.0;1.0;0.896240625180289;9.628524252492122;579.9307786885206;7.697632086000634;0.019409761258888828;0.7898978880348613;[SLC27A2]
GO:0046900;tetrahydrofolylpolyglutamate metabolic process;7.0;0.9326813400603323;0.8172600352873667;9.582004236857228;233.86979834373935;9.083926447120524;0.007827411681411262;0.8154717862087246;[GGH]
GO:0001676;long-chain fatty acid metabolic process;8.0;0.6835726970475526;0.7167863485237763;8.866384200445225;93.73125239075797;5.049685808968129;0.0031371006648681556;0.6332411671050352;[, CYP1B1, ACSL1, CYP4A11, ACSL5, ELOVL6, ACSBG1, SLC27A3, SLC27A2, HSD17B4, ALOX12, PTGS2, CYP3A4, PTGS1, ALOX5, PNPLA8, CYP4F2, CYP4F3, CYP4F12, TBXAS1, PLP1]
GO:0051256;mitotic spindle midzone assembly;5.0;1.0;0.7902410118609202;9.628524252492122;55.94550109770304;7.474488534686424;0.001872445574057981;0.6724867031240476;[RACGAP1, KIF4A, AURKB]
GO:0030539;male genitalia development;5.0;1.0;0.7902410118609202;9.628524252492122;66.31594138202881;6.832634648514029;0.002219534877584045;0.639662265535933;[PDGFRA, LHCGR, DHCR24, LGR4]
GO:0033489;cholesterol biosynthetic process via desmosterol;8.0;1.0;0.875;9.628524252492122;431.4567121071901;8.390779266560578;0.014440467868396407;0.8041048419030481;[DHCR24]
GO:0070317;negative regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;83.03241800612349;6.139487467954083;0.002779020306340262;0.6648930398837374;[EHMT2, BRCA1, BMI1, UXT, CHEK1, RBBP8, E2F1, RRM2, RAD51, TFDP1, EZH2]
GO:2001178;positive regulation of mediator complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;9.083926447120524;0.004698449899916962;0.8154717862087246;[CDT1]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[ITGB5, ARRB1, AIF1, EPS8, PLS1, ACTN1, PAWR, ACTN4, SORBS1, MARCKS, ZYX, LCP1]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[PPP2R1A, CDC25A, MSH6, BLM, CCNB1, PRKAR2B, RAD21, NAE1, FANCI, PLK1, CDC6, CDK6, CDK1, BRCA1, TOPBP1, TUBG1, RAD51C, DTL, SMARCD3, VPS4B, AURKB, DONSON, CENPF]
GO:0032270;positive regulation of cellular protein metabolic process;7.0;0.47017759384120705;0.586008162177804;7.412950536487706;288.49227156764;2.455885070940991;0.00965557670318086;0.47651344199545814;[, AKT1, PRKACB, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, SLC30A10, IQGAP3, GATA1, C3, PRKAR2B, PDGFD, PDGFC, LYN, JUN, FN1, EIF2AK2, AZU1, NOX4, NOX1, EZH2, GPR37, RIPK2, SIRT1, F3, DUSP6, CKS2, PTAFR, PTGS2, NTF3, CASP8AP2, CENPE, PSMC6, PSMC2, PKN1, CCNT2, NCF1, CTGF, RUVBL2, PPP1R16B, IFNA14, IFNA16, ADCYAP1, S100A9, S100A8, IFNA10, TNFRSF11A, IFNA21, TNFRSF10B, PTPRC, LRRK2, ITGB3, FASLG, ARRB1, ARRB2, PPP1R12A, TNFRSF1B, LCP2, BIRC2, BIRC3, PPP1R15A, LRP1, UHRF1, LRP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, TIE1, EIF3E, FCGR2B, EIF3D, CCNH, CCNC, ICAM1, CDC20, TCL1A, TNFSF11, EPHB2, EPHB1, MIF, EREG, SFRP2, IFI27, TRIB1, EPHA3, EPHA2, TGFA, PIK3R5, SLAMF1, CCR1, EGR1, PTK2, CD28, CD27, CALM3, CD24, NRP1, CD40, BRCA1, CD3E, BMI1, CTSH, CCR7, CD36, SYK, IL18, RNF144B, BANK1, IL1B, KIT, GNAI2, PAK1, RXRA, PERP, CD74, IL33, OSM, NLRP12, RAMP1, CD80, IL6R, PDGFRB, PDGFRA, PCOLCE, CALCA, PSMD14, RASGRP1, CCNB1, ECT2, CAV2, UBE2C, CAV1, INHBA, GH1, IL6, BMP2, TNFAIP3, GHR, GRM5, MMP9, GREM1, PSRC1, CHI3L1, EGF, MAPK14, CD4, TEK, PHB2, MYB, PROK2, DAPK1, PRKCE, PRKCD, PRKCZ, S100A12, NCKAP1L, ELANE, FZD1, NDFIP2, ACE, FZD5, PLK2, PLK1, FZD8, UPF3B, CDC6, CDKN1A, TIMP2, HAVCR2, FCRL3, HCLS1, PLCB1, HBEGF, ENG, CCL13, FAM129A, GPNMB, CCL19, CCL18, CCL23, GSN, CCL21, CCL20, NR1H2, CARD9, CSF3, FMR1, TNF, CLU, PYCARD, MAP2K2, IGFBP3, F2R, ADAM9, ADAM8, CSF1R, PSAP, DRD4, MAP2K6, FANCI, OSBPL7, WFS1, DAB2, BCL6, BCL3, CDK1, BCL2, CSPG4, CCDC22, LAT, TREM2, PTPN22, CYR61, CR1, ASPH, LCK, XCL2, XCL1, CEBPA, HDAC2, NLRC4, NOD2, CSK, KLF4, PML, RAD50, P2RX1, IL1RN, ANTXR1, EDNRB, SKP2, SOX7, SOX4, ACSL1, SLC11A1, FLT3LG, IL23A, AURKAIP1, LIF, MARCO, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, MAP4K1, EDN1, STRADB, PARP9, CBFA2T3, MDFIC, TLR6, TLR4, CXCR4, AIF1, LILRB2, CD40LG, DLC1, CAMK1, C5AR1, FBLN1, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NFKBIA, LIN28A, PLAUR, AXIN2, IFNG, PDE5A, LTF, THBS1, HSPD1, SNCA, HSPE1, LTBR]
GO:0007077;mitotic nuclear envelope disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;74.08347249058063;7.292166977892469;0.002479507153463127;0.6960420709600095;[CCNB2, CCNB1, PLK1, CDK1, VRK1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, HLA-G, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, NOX4, SNAI2, SRPX, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, CDK6, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0080111;DNA demethylation;9.0;0.8653626801206646;0.8289219652406215;9.537552474286395;342.028404744498;6.781341354126479;0.011447382901218509;0.7430387373949403;[APOBEC3A, APOBEC3B]
GO:0051271;negative regulation of cellular component movement;5.0;0.5470854108181258;0.5637837172699831;7.364160372318274;52.38761662992485;4.128099389519264;0.001753366382809582;0.5013522066171892;[SEMA5B, IL1RN, SERPINE1, SPINT2, ADARB1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, SEMA6A, IGFBP5, ACTN1, IGFBP3, TPM1, ACTN4, MIF, SFRP2, PADI2, TRIB1, VCL, KCNE3, TACSTD2, FBLN1, GATA3, THY1, PKHD1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, NRP1, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, TGFBR3, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, SPOCK3, CTNNA1, CCL2, IL33, SEMA4A, CCL21, SEMA4B, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1, CD9]
GO:1905448;positive regulation of mitochondrial ATP synthesis coupled electron transport;12.0;0.9326813400603323;0.9144609826203107;9.600353375525426;1375.5648477489242;8.390779266560578;0.04603891752616661;0.8772251544931927;[CCNB1, CDK1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RXRA, IL33, CDX1, OSM, LILRB1, GRHL2, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[CTSZ, FASLG, MYB, JUN, TGFB2, CDC34, IL1B, UBE2M]
GO:1902977;mitotic DNA replication preinitiation complex assembly;8.0;1.0;0.875;9.628524252492122;93.82476133550486;9.777073627680469;0.003140230325096247;0.875;[CDC45]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, IL6, NR4A3, NOX1]
GO:0051383;kinetochore organization;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;38.75571468247735;6.8867018697843045;0.0012971188925437662;0.6424272657460779;[CDT1, MIS12, SMC4, CENPA, NDC80, SMC2, CENPE, CENPF, CENPH, CENPK, NUF2, CENPN]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, IL6, BCL2, ALPL, SDC1, FOSB]
GO:0019860;uracil metabolic process;8.0;0.8653626801206646;0.8076813400603323;9.52844079393514;250.73952180582577;8.67846133901236;0.008392026143921861;0.8188169164668168;[DPYS, DPYD, TYMS]
GO:0019985;translesion synthesis;9.0;0.8933024483968273;0.8428918493787028;9.572954401337311;760.2225735865501;6.063501560976162;0.025443965382044766;0.706328376990269;[PCNA, POLD3, POLD1, TRIM25, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, ISG15, POLE2, RPA3, DTL]
GO:2000773;negative regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.4250159730019;7.004484905440688;0.005503157311709213;0.7091290490632969;[CDK6, BCL6, PLK2, TWIST1, SLC30A10, SIRT1]
GO:0014038;regulation of Schwann cell differentiation;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;65.83981520803086;8.67846133901236;0.0022035993630260702;0.8400575416471059;[CDK1]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, ARRB2, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC2, BIRC3, FAM105A, USP1, IL33, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0090166;Golgi disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;58.9131161342151;7.9853141584524145;0.001971768978649902;0.6986103492792611;[CDK1, VRK1]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[HERC5, SKP2, FBXW2, CDC34, BARD1, HACE1, UBE2C, MARCH1, BCL2, TNFAIP3, BRCA1, RNF144B, DTL, BIRC2, ZNRF1, RNF24, NEDD4]
GO:0009263;deoxyribonucleotide biosynthetic process;9.0;0.6913464685778243;0.7419138594692012;9.253830803050711;956.1008338098185;6.943860283624253;0.03199983447272836;0.7513499630073597;[DTYMK, RRM1, RRM2, TYMS]
GO:1902983;DNA strand elongation involved in mitotic DNA replication;11.0;0.8933024483968273;0.8790801765280758;9.541512875502493;179.04351465331663;9.777073627680469;0.005992425306744681;0.9324289523296623;[GINS1]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, HDAC2, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0072757;cellular response to camptothecin;7.0;1.0;0.8509193652572005;9.628524252492122;502.88914831670934;8.390779266560578;0.016831247223310163;0.7800242071602487;[BLM, RAD51]
GO:0000819;sister chromatid segregation;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;40.65143508701015;6.221725566191056;0.0013605669484458803;0.6084203466557585;[TOP2A, MIS12, PLK1, CDCA8, SMC1A, TUBG1, SMC4, ZWINT, NDC80, KIF18A, RAN, MAD2L1]
GO:0072708;response to sorbitol;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;29.400638164542393;8.16763571524637;9.840129005107402E-4;0.7079342821725234;[CDT1, MAP2K6, MAPK13]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, CCNB1, CDK1, MAPK14]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, TRIP13, CCNT2, ARID4A, ETS1, HOXA10, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL1, MYOCD, KLF13, NCBP2, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:1904899;positive regulation of hepatic stellate cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;82.02400851358074;9.777073627680469;0.0027452697481344787;0.8509193652572005;[MYB]
GO:0008543;fibroblast growth factor receptor signaling pathway;8.0;0.7090535922965819;0.729526796148291;8.567652291806858;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[CTGF, FGF5, FLRT2, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, NCBP2, SHCBP1, KIF16B, ESRP1]
GO:0051445;regulation of meiotic cell cycle;5.0;0.5498737448241444;0.5651778842729924;7.5284634236095505;25.888472835594534;5.8650506222523235;8.664638876944386E-4;0.5901799734356507;[BRCA2, CDC20, PPP2R1A, FBXO5, PRKACB, DUSP1, LIF, CDC25A, ASPM, MSH2, CDK1, TRIP13, PLCB1]
GO:0042063;gliogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;7.9853141584524145;7.282666309192915E-4;0.6986103492792611;[ANXA1, CDK6]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC2, BIRC3, LEF1, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[MEF2C, ACTN1, NBEAL2, GATA1, TAL1, PTPN6]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[ACTN1, PTPRK, SORBS1, THY1, ARHGAP6, DLC1, BCL2]
GO:0017148;negative regulation of translation;8.0;0.6493065804076676;0.6996532902038338;9.081980546124052;1114.6737408694362;4.99795013456894;0.03730712696566269;0.6305954023103058;[BTG2, FMR1, IGFBP5, DAPK1, SRP9, BANK1, RARA, TYMS, PURA, EIF2AK2, EIF2S1, LIN28A, CNOT3, EIF3E]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[SMARCD3, VPS4B, CDC25A, CCNB1, RAD51C, CDK1, DTL]
GO:0042987;amyloid precursor protein catabolic process;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;48.551292581453126;7.57984905034425;0.0016249680693747237;0.710754145523778;[PSEN2, DHCR24]
GO:0000707;meiotic DNA recombinase assembly;8.0;0.8259837884571596;0.7879918942285797;9.405380701177911;133.9647452985807;7.697632086000634;0.004483679464700174;0.7686572628545723;[RAD51, RAD51C]
GO:0007344;pronuclear fusion;6.0;1.0;0.8231203125901445;9.628524252492122;29.37726267204044;9.777073627680469;9.832305438132773E-4;0.8231203125901445;[CDK1]
GO:0071163;DNA replication preinitiation complex assembly;7.0;0.8653626801206646;0.7836007053175329;9.387362195675234;77.2272886234996;8.67846133901236;0.002584727850181096;0.7947362817240173;[CDT1, CDC45, GMNN]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[, CDC20, TRIM25, SKP2, CDC34, PLK1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PCNP, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, PSMD14, CCNB1, WFS1, UBE2C, CDK1, ARRB1, ARRB2, BIRC2, AURKB, ZNRF1, TBX21, RNF24, PML]
GO:0051574;positive regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;804.3299673530898;7.474488534686424;0.02692020015733362;0.8146746435927894;[MYB, BRCA1, SIRT1]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, ARRB1, ARRB2, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, UHRF1, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, CCNC, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, NCBP2, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, TBX21, RBM38, EGF, MAPK14, CD4, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, UPF3B, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DAB2, COPS5, MAFB, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, CDX2, CDX1, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0051571;positive regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.004484905440688;0.026910571697265715;0.7906386361357586;[MYB, BRCA1]
GO:0055015;ventricular cardiac muscle cell development;7.0;1.0;0.8509193652572005;9.628524252492122;69.56390858866273;7.379178354882098;0.002328241417009372;0.728290889492758;[CCNB1, CDK1, FHL2, MYH10]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCE, PRKCD, VRK1, PRKCQ, PRKCZ, CCNB1, PLK2, PLK1, CLK1, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, SGK1, CAMK2D, AURKB, MAPK14, MAPK13, CAMK4, PKN1, CAMK1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCD, CAD, VRK1, CAMK2D, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0033160;positive regulation of protein import into nucleus, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;970.0189350156829;7.292166977892469;0.03246566079461078;0.7881627702307852;[MED1, IFNG, LRRK2, CDK1]
GO:0008089;anterograde axonal transport;9.0;0.8259837884571596;0.8092325194088689;9.405380701177911;71.1020239957658;6.113511981550823;0.0023797207554711163;0.7088859122241795;[FMR1, RAB21, KIF4A]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[, SLA2, MYLK, AKT1, PRKACB, MEF2A, MED1, MEF2C, PRKCH, DAPK1, PRKCE, PRKCD, PRKAR1B, PRKCQ, PDGFA, THY1, IQGAP3, PRKCZ, LYN, PLK2, PLK1, EIF2AK2, CDK14, ITK, JAK3, RIPK2, DUSP6, CIT, RARA, HBEGF, IL12RB2, GTF2H1, PKN1, CCNT2, IL5RA, SLA, TNF, FGF5, EFEMP1, GRAP2, STK32B, KCNH1, MEN1, KCNH2, MAP2K2, IGFBP3, VRK1, NRBP1, MELK, BLK, CSF1R, PKMYT1, MAP2K6, NEK7, BMX, NFKB1, CDK6, CDK1, BCL2, LAT, LRRK2, PIK3CD, TLK1, CHUK, SPTB, LCK, IL3RA, BIRC5, NOD2, IL2RG, CCL8, CCL5, CCL2, FYN, CSK, TIE1, PML, IL2RB, PTPN6, CCNH, CCNC, CHEK1, RPS6KA1, TNFSF11, EPHB2, EPHB1, PAQR3, EREG, BTC, BTK, SIK1, ALPK2, TRIB1, EPHA3, EPHA2, TXK, LIF, PTK2, CTSH, CTSG, CCR5, SPTAN1, MAP4K1, SYK, STRADB, IL18, GFRA3, HCK, IL1B, KIT, FAM20C, TLR7, SGK1, TLR4, TLR2, GUCY2C, PAK1, PRKY, KITLG, CAMK4, CAMK1, BUB1B, PDGFRB, PDGFRA, MATK, CCNE1, CSF2RB, CSF2RA, RASGRP1, RASGRP4, SPTA1, CCNB1, TGFB2, TGFB1, EIF2S1, CLK4, CLK1, BMP2, FES, GHR, CAD, IRAK3, TGFBR3, FGR, CCNA2, ZAP70, SHANK3, CAMK2D, AURKB, NCAM1, BUB1, EGF, MAPK14, MAPK13, WEE1, TEK]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, FMR1, PRF1, ADARB1, IFIT1, TNF, CLU, IFIT3, IFIT2, PYCARD, HERC5, STMN1, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, GATA3, DDX60, NLRP3, IFNA21, HMGA1, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, CXCL12, PTPRC, CDK6, BCL3, BCL2, SERINC5, APOBEC3A, BCL2L1, APOBEC3B, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, CHUK, IFNGR1, DDX58, IFNGR2, IRAK3, PARP9, MMP12, ACTA2, EEF1G, FGR, PLSCR1, IFNG, OAS1, PSMA2, OAS3, IRF7, TLR8, XCL1, TLR7, ZMYND11, EXOC1, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, TBX21, CCL4, CCL19, CCT5, IL33, MX2, CARD9, LILRB1, MAPK14, PML]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, TAL1, RARA, HCLS1, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RXRA, CDX2, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CSF3, SPI1, SPARC, TNC, ICAM1, EEF1B2, ALAD, PRKCE, CYBB, ADCYAP1, CLDN3, IL1B, CLDN7, RARA, S100A8, BIRC2, PSMD14, FECH, GATA3, TYMS, CCL7, CNR1, FYN, CD14, GSN, VCAM1, GGH, CDK1, CD27]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, CEBPB, PCNA, TGFB1, IHH, TYMS, SULF2, NFKBIA, HMOX1, EZH2]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, ADM, ICAM1, SESN3, AKT1, IL10, GHSR, CAD, SIRT1, CEACAM1, RAB31, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, GGH, SORBS1]
GO:0031658;negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle;13.0;1.0;0.9625549647676366;9.628524252492122;3330.314475181895;7.8311634786251565;0.11146262839589782;0.8630410292508717;[CDKN2C, CDK6]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[BLM, MCM7, RAD54B, PURA, CDC45, RUVBL2, RUVBL1, GINS1, GINS2, ANXA1, HMGA1, RPA1, RAD50, RAD51, MCM4, MCM6, MCM2]
GO:0010833;telomere maintenance via telomere lengthening;8.0;0.9326813400603323;0.8413406700301662;9.590783924509275;185.09737597092234;6.409777797693995;0.00619504259692348;0.7027963346592216;[RFC1, RPA1, RAD50, RAD51]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0071636;positive regulation of transforming growth factor beta production;6.0;0.7980440201809971;0.722142322680643;9.34084218004034;65.64212018022187;6.943860283624253;0.0021969826883592772;0.6782296504172152;[LUM, MYB, XCL1, PTGS2, THBS1, CD34]
GO:0051106;positive regulation of DNA ligation;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;378.6008333431687;8.16763571524637;0.012671429173367173;0.7926932703116032;[RAD51]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[PCNA, POLD3, POLD1, USP1, SOX4, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA3, DTL]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6, AIF1, CDC45, PLCB1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, HHEX, BIRC5, BIRC2, UHRF1, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, HMGB2, AFF3, LYL1, NUP62, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, RAD21, PRDM16, NKX2-3, NFE2, SNAI2, BTG2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, LMO2, COL4A2, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SPI1, SLA2, SPIB, AKT1, MNX1, ATF3, CDCA7, GATA3, GATA1, JUN, JAG1, JUP, EIF2AK2, NR2F2, PKIG, HOXC10, CHAF1B, FOS, MMP12, MED23, PLSCR1, PTAFR, SPP1, ZNF467, CASP8AP2, ATAD2, NOC3L, CENPF, PKN1, LGR4, GMNN, EFEMP1, BLM, G3BP2, ZNF423, CIITA, ITGB2, HHEX, UHRF1, CDC45, E2F1, E2F2, E2F5, E2F7, POU2AF1, SMARCAL1, IKZF1, ICAM1, TNFSF11, TRIM25, FBXO5, BTK, TRIB1, TGFA, PKHD1, EGR1, EGR2, EGR3, POLA1, ECM1, IL10, SYK, IL18, IL1A, IL1B, KIT, DEPDC1, YAP1, PCNA, IL33, OSM, ETS1, NR3C2, LOXL2, CARD11, TCF7, HTRA1, LPXN, CAV1, UBA3, TCF4, MXD1, FBN1, PLEK, TNFAIP3, LYL1, MYBL1, MYOCD, NUP133, IRAK3, ETV1, GREM1, ELF3, ZMYND11, FBP1, TBX21, RRM2, CD4, PHB2, PRKCH, PRKCQ, PRKCZ, NUP85, PRDM16, HMOX1, NFE2, PLK1, SNAI2, CDKN1A, BTG2, ZNF367, RARA, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, ELP4, FOSB, PF4, CSF3, PLXND1, TNF, CLU, TLE4, MAP2K2, AEBP1, MAP2K6, DAB2, COPS5, BCL6, BCL3, CCDC22, SLC26A3, CYR61, LBH, EMILIN1, RFC1, TFDP1, XCL1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, NLRC3, NLRC4, NOD2, ABLIM3, POLR2K, POLR2L, PML, DNAJA3, PPIL4, GFI1, PPP2R1A, RPS6KA1, FLT3LG, NIF3L1, IL23A, SIK1, TXK, TWIST1, LIF, TOP2A, AHCTF1, IFNA2, PRL, XPO1, HBZ, EDN1, PARP9, CBFA2T3, VAV1, MLF2, HCK, TLR6, TLR4, TLR2, TYMS, PURA, GRHL2, CD40LG, HOXA11, HOXA10, LMO2, FANCD2, NLRP3, CBX4, KDM5D, SLC40A1, H2AFX, DCN, DNM2, PFDN5, LTF, LEF1, HLX, SNCA, LUM, RBMX, PID1, EHMT2, MEF2A, MEF2C, ZFYVE16, PADI2, PADI4, HESX1, MCTS1, HACE1, COL1A1, EZH2, RIPK2, ACTL6A, SIRT1, PSMA6, CKS2, FSTL1, BTAF1, STAT4, FLNA, USP9Y, PSMC6, PSMC2, CCNT2, NCF1, RORA, RUVBL2, RUVBL1, ADCYAP1, S100A9, S100A8, MAZ, TNFRSF11A, FOXO1, NFKB1, NFKB2, CXCL10, MYD88, FHL2, FASLG, ARRB1, ARRB2, PPP1R12A, PEG3, BIRC5, BDP1, BIRC2, LRP2, PRRX1, CCNH, CCNC, UXT, TMPO, HNF1B, EREG, SFRP4, SFRP2, IFI27, PCBP3, ZNF700, OR7D2, ID1, CD28, CD40, SUV39H1, HNF4G, PTPRK, BRCA1, BRCA2, PCSK6, BMI1, CD3D, HNF4A, CD38, CD36, RGMA, SATB2, RXRA, CD74, NLRP12, NEDD4, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, EOMES, CCNE1, CALCA, VDR, HMGA1, INHBA, IL6, BMP2, HMGB2, ARHGEF10L, AFF3, NUP62, YWHAH, DDX58, CCNA2, PSRC1, IRF7, IRF8, CREB5, TAF9, AURKB, EGF, MAPK14, SOD2, MAPK13, NUP35, TAF5, NAA15, RAN, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, CYP1B1, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, RAD21, S100A12, ELANE, NKX2-3, FZD1, FZD5, FZD8, CDC6, TGFB1I1, HAVCR2, BRD2, ANXA3, NFAM1, PAWR, PAX5, PAX2, AES, TAL1, HCLS1, PLCB1, ENG, GTF2H1, SULF1, POU4F1, PYCARD, DACH1, CDH1, MEN1, F2R, ADAM8, NACC2, WFS1, HOPX, MAFB, CNOT3, MAFF, CHUK, TRAF1, SMARCD3, RBBP8, ZNF503, IRX3, KLF4, KLF1, KLF8, KLF6, KLF5, MNDA, ZNF608, EDNRB, CHEK1, DPF3, SOX7, SOX4, SLC11A1, EBF1, RUNX2, PFN1, BEX1, SP140, NHLH2, CDT1, BCL11B, BCL11A, RHOG, RHOH, MDFIC, TFEC, SGK1, SP100, CDX2, CDX1, LILRB1, CAMK4, CAMK1, ARID4A, ARID4B, CHCHD3, BASP1, ADRB2, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, JMY, CREBZF, TMEM100, KLF12, KLF13, CKAP2, TGFBR3, IFNG, CAMK2D, DLL1, HSPD1, MEIS2, MEIS1]
GO:0042760;very long-chain fatty acid catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;525.4628036644517;7.8311634786251565;0.017586767152828246;0.7967266896635242;[SLC27A2]
GO:0006231;dTMP biosynthetic process;12.0;0.9326813400603323;0.9144609826203107;9.610505746989444;6271.9915988638395;8.390779266560578;0.2099179143880009;0.8772251544931927;[TYMS]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, ICAM1, NUP62, CHEK1, MME, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, PML, DNAJA3, CDK1, BCL2, NOX4, ENG]
GO:0006235;dTTP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6270.758393425197;8.390779266560578;0.20987664011178236;0.8772251544931927;[DTYMK, TYMS]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[PLK1, NAV1, PSRC1, FES, PRC1, MAP1B, KIF20A]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, NOX1, SRPX, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, PLEKHF1, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0051593;response to folic acid;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;113.95729645358138;7.379178354882098;0.003814048157392989;0.728290889492758;[GSN, TYMS]
GO:2000105;positive regulation of DNA-dependent DNA replication;9.0;0.7763722522362496;0.7844267512984139;9.440472020989182;901.5417397663175;7.379178354882098;0.03017379069508918;0.7736121494158466;[CDT1, E2F7]
